316 related articles for article (PubMed ID: 19073408)
21. [Construction of recombinant adenovirus carrying human IFNgamma gene by in vitro ligation and its expression].
Xue G; Li Y; Liu RY; Tian FZ; Huang WL
Ai Zheng; 2006 Jun; 25(6):771-4. PubMed ID: 16764779
[TBL] [Abstract][Full Text] [Related]
22. Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification.
Tang N; Wang Y; Wang X; Zhou L; Zhang F; Li X; Chen Y
J Cell Biochem; 2012 Feb; 113(2):518-27. PubMed ID: 21938740
[TBL] [Abstract][Full Text] [Related]
23. Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver.
Nedredal GI; Elvevold K; Ytrebø LM; Fuskevåg OM; Pettersen I; Bertheussen K; Langbakk B; Smedsrød B; Revhaug A
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G75-83. PubMed ID: 17363468
[TBL] [Abstract][Full Text] [Related]
24. Ammonia removal using hepatoma cells in mammalian cell cultures.
Choi YS; Lee DY; Kim IY; Kang S; Ahn K; Kim HJ; Jeong YH; Chun GT; Park JK; Kim IH
Biotechnol Prog; 2000; 16(5):760-8. PubMed ID: 11027167
[TBL] [Abstract][Full Text] [Related]
25. Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver.
Enosawa S; Miyashita T; Suzuki S; Li XK; Tsunoda M; Amemiya H; Yamanaka M; Hiramatsu S; Tanimura N; Omasa T; Suga K; Matsumura T
Cell Transplant; 2000; 9(5):711-5. PubMed ID: 11144971
[TBL] [Abstract][Full Text] [Related]
26. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.
Wilkening S; Stahl F; Bader A
Drug Metab Dispos; 2003 Aug; 31(8):1035-42. PubMed ID: 12867492
[TBL] [Abstract][Full Text] [Related]
27. Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver.
Yamashita Y; Shimada M; Tsujita E; Tanaka S; Ijima H; Nakazawa K; Sakiyama R; Fukuda J; Ueda T; Funatsu K; Sugimachi K
Cell Transplant; 2001; 10(8):717-22. PubMed ID: 11814114
[TBL] [Abstract][Full Text] [Related]
28. [The killing effect and bystander effect of linamarase/linamarin suicide gene system on human hepatocellular carcinoma cell line HepG2 in vitro].
Chen MH; Ma J; Li HM; Li J; Li R; Zhang FQ; Dou KF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):274-7. PubMed ID: 18328192
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver.
Poyck PP; van Wijk AC; van der Hoeven TV; de Waart DR; Chamuleau RA; van Gulik TM; Oude Elferink RP; Hoekstra R
J Hepatol; 2008 Feb; 48(2):266-75. PubMed ID: 18093687
[TBL] [Abstract][Full Text] [Related]
30. The HepaRG cell line is suitable for bioartificial liver application.
Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Lamers WH; Elferink RP; Chamuleau RA
Int J Biochem Cell Biol; 2011 Oct; 43(10):1483-9. PubMed ID: 21726661
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver.
Gebhardt R; Baldysiak-Figiel A; Krügel V; Ueberham E; Gaunitz F
Prog Histochem Cytochem; 2007; 41(4):201-66. PubMed ID: 17368308
[TBL] [Abstract][Full Text] [Related]
32. Loofa sponge as a scaffold for the culture of human hepatocyte cell line.
Chen JP; Yu SC; Hsu BR; Fu SH; Liu HS
Biotechnol Prog; 2003; 19(2):522-7. PubMed ID: 12675596
[TBL] [Abstract][Full Text] [Related]
33. Construction and evaluation of drug-metabolizing cell line for bioartificial liver support system.
Omasa T; Kim K; Hiramatsu S; Katakura Y; Kishimoto M; Enosawa S; Ohtake H
Biotechnol Prog; 2005; 21(1):161-7. PubMed ID: 15903254
[TBL] [Abstract][Full Text] [Related]
34. [Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells].
Chen XL; Wang Q; Cao LQ; Huang XH; Fu XH; Tan HX; Zhen MC; Chen JS
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2524-8. PubMed ID: 19080641
[TBL] [Abstract][Full Text] [Related]
35. Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth.
Sun D; Gong Y; Kojima H; Wang G; Ravinsky E; Zhang M; Minuk GY
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G12-9. PubMed ID: 12799308
[TBL] [Abstract][Full Text] [Related]
36. [Construction of eukaryotic expression vector encoding ACRBP and its expression in hepatocarcinoma cells].
Luo B; Yun X; Lin YD; Xiao SW; Yan GH; He SJ; He SJ; Chen F; Xie XX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1072-4. PubMed ID: 21968305
[TBL] [Abstract][Full Text] [Related]
37. Modulation of different stress pathways after styrene and styrene-7,8-oxide exposure in HepG2 cell line and normal human hepatocytes.
Diodovich C; Urani C; Maurici D; Malerba I; Melchioretto P; Orlandi M; Zoia L; Campi V; Carfi' M; Pellizzer C; Gribaldo L
J Appl Toxicol; 2006; 26(4):317-25. PubMed ID: 16705669
[TBL] [Abstract][Full Text] [Related]
38. Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2.
Guo L; Song L; Wang Z; Zhao W; Mao W; Yin M
Chem Biol Interact; 2009 Sep; 181(1):138-43. PubMed ID: 19450571
[TBL] [Abstract][Full Text] [Related]
39. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
[TBL] [Abstract][Full Text] [Related]
40. Effects of glucose and insulin on HepG2-C3A cell metabolism.
Iyer VV; Yang H; Ierapetritou MG; Roth CM
Biotechnol Bioeng; 2010 Oct; 107(2):347-56. PubMed ID: 20506178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
